Sign in
Taking peopleNo phase

Respiratory Physiotherapy and Inflammatory Biomarkers in Critically Ill Patients With Pneumonia

Key facts

Who runs it
Hospital H+ Queretaro
Where
Mexico1 site in 1 countryChoose a country to see its sites
Trial code
Status
Recruiting
People taking part
180 people, planned
Started
8 Sept 2026
Expected to end
1 Dec 2026
Type of study
Observational, 2 groups
Treatments tested
  • Protocolized Respiratory Physiotherapy Program
Record updated
2 November 2026

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part
Show the full registry criteria (6)Hide the full registry criteria

Who can take part

  • Consecutive adult patients (age >= 18 years at the time of admission)
  • Confirmed diagnosis of pneumonia (community-acquired, hospital-acquired, or ventilator-associated pneumonia) as the primary cause of ICU admission or critical complication
  • Anticipated or actual ICU length of stay >= 48 hours

Who cannot take part

  • Concomitant severe non-infectious systemic inflammatory diseases that massively alter or mask procalcitonin response (e.g., severe acute pancreatitis, extensive burns)
  • Presence of limitation of medical treatment orders or exclusively palliative management upon admission
  • Refractory hemodynamic instability or uncontrolled septic shock with escalating vasopressor requirements that contraindicate physical manipulation

Eligibility questionnaire

From the criteria published for this trial, to help you prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.

  • Age
  • Pneumonia or critical illness

This trial is currently available in Mexico.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

The goal of this observational study is to evaluate the safety and impact of a protocolized respiratory physiotherapy program on the dynamics of systemic inflammatory biomarkers (procalcitonin [PCT] and C-reactive protein [CRP]) in critically ill adult patients with pneumonia in the intensive care unit (ICU), compared with standard medical care.

Read full original descriptionShow less

The main questions it aims to answer are:

Does a protocolized respiratory physiotherapy program accelerate the decline of PCT and CRP levels in critically ill patients with pneumonia compared to standard care? What is the incidence and safety profile of adverse events (e.g., transient desaturation, hemodynamic instability, or mechanical displacement) associated with respiratory physiotherapy sessions?

Researchers will compare a prospective cohort receiving structured respiratory physiotherapy against a historical control group receiving standard care to determine changes in inflammatory trajectories and ICU length of stay. Participants in the prospective intervention group will:

* Receive an individualized, protocolized respiratory physiotherapy regimen (including high-frequency chest wall oscillation [HFCWO], intrapulmonary acoustic percussion, positive expiratory pressure [PEP], and/or inspiratory muscle training [IMT]) tailored to their clinical deficits. * Undergo continuous safety monitoring during and up to 30 minutes following each physiotherapy session. * Have serum PCT and CRP levels measured at baseline (T0), Day 3 (T1), Day 7 (T2), and at ICU discharge (T3).

The 2 groups in the trial

  • Prospective Intervention Group

    Adult patients admitted to the ICU with a confirmed diagnosis of pneumonia who receive an individualized, protocolized respiratory physiotherapy program (including high-frequency chest wall oscillation, intrapulmonary acoustic percussion, positive expiratory pressure, and inspiratory muscle training) alongside standard care.

    Treatment: Protocolized Respiratory Physiotherapy Program

  • Historical Control Group

    Retrospective historical cohort of adult patients admitted to the ICU with pneumonia who received standard medical, ventilatory, and nursing care without specialized protocolized respiratory physiotherapy.

Next steps

For your doctor

Doctor ask sheet

A PDF for your doctor: what this trial tests, who can take part, and 2 eligibility questions with room for answers and notes.

Download the PDF

PDF, US Letter, 1 to 2 pages. A4 size

For the study team

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Dynamics of Procalcitonin and C-Reactive Protein Associated With Respiratory Physiotherapy in Critically Ill Patients With Pneumonia
Criteria questions
Built from NCT07909616, who can take part
Record updated
2 November 2026